PurpleStride is the number one way the Pancreatic Cancer Action Network (PanCan) raises money to fight pancreatic cancer on all fronts — through research, clinical initiatives, patient services, advocacy, and nationwide volunteer support. On Saturday, April 29, 2023, 60 PurpleStride events took place across the country to honor pancreatic cancer survivors, families, and caregivers, as … Continue reading PanCAN PurpleStride 04 -29 -2023
Der Lab Volunteers at SECU Family House
December 15, 2019 On Sunday, the Der lab prepared a taco bar for the guests at the Family House. Together, they made ground beef, rice, beans, vegetables, and homemade pico de gallo served in soft tacos, as well as cookies and sweet tea. The Der lab also had the opportunity to sit down and eat … Continue reading Der Lab Volunteers at SECU Family House
Der Lab Goes Purple for Pancreatic Awareness
For the month of November, the Der and Cox labs have gone purely purple. The dress code is inspired by the official pancreatic cancer ribbon and is worn all month to bring awareness to pancreatic cancer. See ABC 11's interview with Dr. Jen Jen Yeh and Dr. Kirsten Bryant here. Photos courtesy of the UNC … Continue reading Der Lab Goes Purple for Pancreatic Awareness
Kirsten Bryant Accepts Pagano Award
September 4, 2019 Congratulations to Kirsten Bryant, Ph.D., for her acceptance of the Joseph S. Pagano Award! This award recognizes outstanding work by the Lineberger’s postdoctoral research associates. We are proud of Kirsten's accomplishments. Read more about Kirsten's award ceremony.
Lab Members Learn (and Laugh) at Annual Retreat
This summer, the Der, Cox, Campbell, and Counter labs visited Emerald Isle, NC. Together they spent three days giving talks, getting to know one another, and discussing upcoming projects.
Dr. Kirsten Bryant’s recent publication in Nature Medicine stimulates excitement for a new therapeutic strategy for pancreatic cancer.
Published March 4th, 2019 in Nature Medicine, two new studies describe a combination approach to target the KRAS signaling pathway and a process called autophagy as a way to treat pancreatic cancer patients. Sources: Two Studies Point to New Combination Treatment for Pancreatic Cancer – Pancreatic Cancer Action Network, 3/4/2019 Advancements in Promising New Pancreatic … Continue reading Dr. Kirsten Bryant’s recent publication in Nature Medicine stimulates excitement for a new therapeutic strategy for pancreatic cancer.
PurpleStride Raleigh-Durham 2018: Running RAScals
UNC's Running RAScals (aka the Der Lab at UNC Lineberger & Friends) participated in this year’s PanCAN #PurpleStride run on Saturday, April 21st. This 5k run raises money to support the Pancreatic Cancer Action Network. The team, organized by Kirsten Bryant, raised $10,839 to support Pancreatic Cancer Research, coming in Fifth in overall fundraising! This was the Der Lab's fifth … Continue reading PurpleStride Raleigh-Durham 2018: Running RAScals
News radio 680 WPTF on Pancreatic Cancer
Rick and Donna Martinez have a morning live interview show featuring conversations with community personalities and leaders about issues that impact you. We are happy to share the March 1, 2018 radio podcast with our own Pancreatic Cancer Experts Channing Der, PhD and Kirsten Bryant, PhD. This interview discusses common perceptions of Pancreatic Cancer; Symptoms … Continue reading News radio 680 WPTF on Pancreatic Cancer
World Pancreatic Cancer Day is November 16
Raising pancreatic cancer awareness can be done as an individual or group all year long, but it is especially important during Pancreatic Cancer Awareness Month in November. During this month, we in the Der Lab are taking time to promote the Pancreatic Cancer Action Network's initiative to Demand Better. For Patients. For Survival. On November 16th, which … Continue reading World Pancreatic Cancer Day is November 16
Kirsten Bryant authored a review in Cancer Cell, highlighting studies by Bar-Sagi and colleagues published in Cell.
Mutant RAS-driven cancers are infamously resistant to chemotherapeutics. Reporting in Cell, Grabocka and Bar-Sagi (2016) demonstrate that when subjected to stress, mutant KRAS-dependent lipid production leads to upregulated stress granule formation. This confers not only cell-autonomous cytoprotection but also paracrine establishment of a stress-resistant tumor niche. Mutant RAS Calms Stressed-Out Cancer Cells. Bryant KL, Der CJ. Dev Cell. … Continue reading Kirsten Bryant authored a review in Cancer Cell, highlighting studies by Bar-Sagi and colleagues published in Cell.